LEVITICUS PARTNERS L P 13D/13G Filings for Harvard Bioscience, Inc. (HBIO)

LEVITICUS PARTNERS L P 13D and 13G filings for Harvard Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-08
09:49 am
Purchase		 2025-04-01 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 3,770,352
8.600%		 485,817increase
(+14.79%)		 Filing
2025-03-17
10:33 am
Purchase		 2025-03-14 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 3,284,535
7.500%		 1,139,644increase
(+53.13%)		 Filing
2025-02-04
10:37 am
Sale		 2025-02-03 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,144,891
4.900%		 -163,731decrease
(-7.09%)		 Filing
2024-03-19
1:02 pm
Purchase		 2024-03-18 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,308,622
5.320%		 201,952increase
(+9.59%)		 Filing
2024-01-22
10:55 am
Sale		 2024-01-16 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,106,670
4.940%		 -52,124decrease
(-2.41%)		 Filing
2023-08-28
3:07 pm
Purchase		 2023-08-25 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,158,794
5.060%		 104,887increase
(+5.11%)		 Filing
2023-01-11
1:30 pm
Sale		 2023-01-06 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,053,907
4.930%		 -200,000decrease
(-8.87%)		 Filing
2022-12-21
4:20 pm
Purchase		 2022-12-16 13G Harvard Bioscience, Inc.
HBIO		 LEVITICUS PARTNERS L P 2,253,907
5.410%		 2,253,907increase
(New Position)		 Filing